Akos’ research targets healthcare and biotechnology with bacterial synthetic biology. He earned his PhD in Hungary while working with Csaba Pal and currently he is doing his postdoctoral research with George Church at Harvard.
Akos is interested in advancing genome editing to accelerate evolutionary processes and thus support synthetic genomics and drug development. To this aim, he has so far developed tools to perform precise genome engineering in pathogenic bacteria and hosts for microbial fermentation. His latest project focuses on the predictability of antibiotic resistance and the exploitation of resistance mechanisms for more-effective therapeutic solutions.